Inventor · disambiguated record
Phillip Alper
Also filed as: ALPER PHILLIP · ALPER PHILLIP B
16 granted patents·12 pending applications·40 citations·filing 2004–2024
89Inventor score
Top patents by PatentIndex Score
28 records- 0189US9150568B2Compositions and methods for modulating FXRTULLY DAVID C·Filed 2011·Granted Oct 6, 2015·18 cites·29 claims
- 0283US7307095B2Inhibitors of cathepsin SIRM LLC·Filed 2007·Granted Dec 11, 2007·4 cites·18 claims
- 0382US8153635B2Compounds and compositions as modulators of GPR119 activityALPER PHILLIP B·Filed 2008·Granted Apr 10, 2012·7 cites·17 claims
- 0481US8258156B2Compounds and compositions as modulators of GPR119 activityALPER PHILLIP B·Filed 2011·Granted Sep 4, 2012·6 cites·8 claims
- 0577US2024376099A1Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0672US7507755B2Inhibitors of cathepsin sIRM LLC·Filed 2007·Granted Mar 24, 2009·1 cites·5 claims
- 0765US7256207B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Aug 14, 2007·2 cites·11 claims
- 0864US7732449B2Inhibitors of cathepsin SIRM LLC·Filed 2009·Granted Jun 8, 2010·0 cites·16 claims
- 0963US7173051B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Feb 6, 2007·2 cites·24 claims
- 1063US2021101902A1Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1161US10954233B2Compounds and compositions as inhibitors of endosomal toll-like receptorsNOVARTIS AG·Filed 2017·Granted Mar 23, 2021·0 cites·30 claims
- 1261US7501408B2Inhibitors of cathepsin SIRM LLC·Filed 2007·Granted Mar 10, 2009·0 cites·16 claims
- 1359US2008242671A1Inhibitors of cathepsin sIRM LLC·Filed 2008·Application pending·0 cites
- 1456US7314872B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Jan 1, 2008·0 cites·15 claims
- 1555US2008021025A1Inhibitors of cathepsin sLIU HONG·Filed 2007·Application pending·0 cites
- 1653US7297714B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Nov 20, 2007·0 cites·19 claims
- 1753US2010022515A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2008·Application pending·0 cites
- 1850US2010204200A1Inhibitors of cathepsin sIRM LLC·Filed 2010·Application pending·0 cites
- 1950US2011172244A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2009·Application pending·0 cites
- 2049US7985749B2Compounds and compositions as cathepsin S inhibitorsNOVARTIS AG·Filed 2005·Granted Jul 26, 2011·0 cites·9 claims
- 2149US2011166176A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2009·Application pending·0 cites
- 2248US2012196844A1Compounds and compositions as modulators of gpr119 activityALPER PHILLIP B·Filed 2012·Application pending·0 cites
- 2346US8268996B2Compounds and compositions as cathepsin S inhibitorsLIU HONG·Filed 2011·Granted Sep 18, 2012·0 cites·8 claims
- 2446US2010120807A1Compounds and compositions as modulators of gpr119 activityIRM LLC·Filed 2008·Application pending·0 cites
- 2544US7816542B2Compounds and compositions as TPO mimeticsIRM LLC·Filed 2006·Granted Oct 19, 2010·0 cites·6 claims
- 2642US8153671B2Heterotetracyclic compounds as TPO mimeticsALPER PHILLIP B·Filed 2006·Granted Apr 10, 2012·0 cites·10 claims
- 2739US2015366856A1Compounds and methods for modulating fxrTULLY DAVID C·Filed 2015·Application pending·0 cites
- 2836US2013261108A1Compositions and methods for modulating farnesoid x receptorsTULLY DAVID C·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →